Scholars@Duke
Hilary A. Campbell

Hilary A. Campbell

Adjunct Assistant Professor in the Duke-Margolis Institute for Health Policy
Duke-Margolis Institute for Health Policy
hilary.campbell@duke.edu
JB Duke Hotel, 230 Science Drive, Durham, NC 27708

Selected Publications

Leveraging Policy Changes Made in Response to COVID-19 to Advance Telehealth and Novel Treatment Approaches for People Who Use Opioids: Qualitative Perspectives From Two Rural North Carolina Counties.

Journal Article N C Med J · July 2023 BACKGROUND: The COVID-19 pandemic has been a catalyst for telehealth services for people who use opioids; however, the data show dramatic increases in opioid overdose deaths and ongoing lack of treatment options in North Carolina, particularly among rural ... Full text Link to item Cite

What North Carolina’s Health Workforce Data Can—and Can’t—Tell Us

Journal Article North Carolina Medical Journal · January 1, 2022 North Carolina has some of the country’s best health workforce supply data through cooperation with licensing boards, but the data don’t encompass all health care workers. Workforce demand data are more difficult to track, and it’s even harder to know how ... Full text Cite

State Policy Responses to COVID-19 in Nursing Homes

Journal Article Journal of Long Term Care · January 1, 2021 Context: COVID-19 has a high case fatality rate in high-risk populations and can cause severe morbidity and high healthcare resource use. Nursing home residents are a high-risk population; they live in congregate settings, often with shared rooms, and requ ... Full text Cite

Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review.

Journal Article Ann Intern Med · July 21, 2020 BACKGROUND: The risk for nephrogenic systemic fibrosis (NSF) after exposure to newer versus older gadolinium-based contrast agents (GBCAs) remains unclear. PURPOSE: To synthesize evidence about NSF risk with newer versus older GBCAs across the spectrum of ... Full text Link to item Cite

Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population.

Journal Article J Manag Care Spec Pharm · February 2020 BACKGROUND: Concurrent use of opioids and benzodiazepines is associated with increased risk of opioid overdose and death. Clinical guidelines recommend against this practice and quality measures incentivize plans to minimize concurrent use. OBJECTIVE: To c ... Full text Link to item Cite

Value-based arrangements may be more prevalent than assumed.

Journal Article Am J Manag Care · February 2019 OBJECTIVES: To better understand the prevalence of US value-based payment arrangements (VBAs), their characteristics, and the factors that facilitate their success or act as barriers to their implementation. STUDY DESIGN: Surveys were administered to a con ... Link to item Cite